Sage Therapeutics, Inc.
US ˙ NasdaqGM ˙ US78667J1088
DIESES SYMBOL IST NICHT MEHR AKTIV

SecuritySAGE / Sage Therapeutics, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
D. E. Shaw & Co., Inc. ownership in SAGE / Sage Therapeutics, Inc.

On November 14, 2025 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 0 shares of Sage Therapeutics, Inc. (US:SAGE) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 1,917,284 shares of Sage Therapeutics, Inc.. The current value of the position is $0 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (SAGE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SAGE / Sage Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F SAGE THERAPEUTICS COM 78667J108 0 -100.00 0
2025-08-14 2025-06-30 13F SAGE THERAPEUTICS COM 78667J108 1,917,284 -170,159 -8.15 17,486 5.36 0.0124
2025-05-15 2025-03-31 13F SAGE THERAPEUTICS COM 78667J108 2,087,443 1,367,338 189.88 16,595 324.42 0.0148
2025-02-14 2024-12-31 13F SAGE THERAPEUTICS COM 78667J108 720,105 73,073 11.29 3,910 -16.29 0.0029
2024-11-14 2024-09-30 13F SAGE THERAPEUTICS COM 78667J108 647,032 322,761 99.53 4,672 32.66 0.0040
2024-08-14 2024-06-30 13F SAGE THERAPEUTICS COM 78667J108 324,271 164,933 103.51 3,522 17.96 0.0033
2024-05-15 2024-03-31 13F SAGE THERAPEUTICS COM 78667J108 159,338 -95,329 -37.43 2,986 -45.90 0.0026
2024-02-14 2023-12-31 13F SAGE THERAPEUTICS COM 78667J108 254,667 52,465 25.95 5,519 32.61 0.0048
2023-11-14 2023-09-30 13F SAGE THERAPEUTICS COM 78667J108 202,202 -249,070 -55.19 4,161 -80.39 0.0043
2023-08-14 2023-06-30 13F SAGE THERAPEUTICS COM 78667J108 451,272 3,037 0.68 21,219 12.82 0.0217
2023-05-15 2023-03-31 13F SAGE THERAPEUTICS COM 78667J108 448,235 -141,214 -23.96 18,808 -16.34 0.0201
2023-02-14 2022-12-31 13F SAGE THERAPEUTICS COM 78667J108 589,449 -112,035 -15.97 22,482 -18.16 0.0248
2022-11-14 2022-09-30 13F SAGE THERAPEUTICS COM 78667J108 701,484 -59,201 -7.78 27,471 11.81 0.0328
2022-08-15 2022-06-30 13F SAGE THERAPEUTICS COM 78667J108 760,685 -165,851 -17.90 24,570 -19.88 0.0288
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM 78667J108 926,536 -67,733 -6.81 30,668 -27.49 0.0287
2022-02-14 2021-12-31 13F SAGE THERAPEUTICS COM 78667J108 994,269 -262,022 -20.86 42,296 -24.02 0.0351
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM 78667J108 1,256,291 -60,852 -4.62 55,666 -25.61 0.0502
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM 78667J108 1,317,143 -554,732 -29.64 74,827 -46.59 0.0646
2021-05-17 2021-03-31 13F SAGE THERAPEUTICS COM 78667J108 1,871,875 -323,012 -14.72 140,110 -26.21 0.1353
2021-02-16 2020-12-31 13F SAGE THERAPEUTICS COM 78667J108 2,194,887 -268,179 -10.89 189,880 26.13 0.1698
2020-11-16 2020-09-30 13F SAGE THERAPEUTICS COM 78667J108 2,463,066 340,910 16.06 150,543 70.61 0.1541
2020-08-14 2020-06-30 13F SAGE THERAPEUTICS COM 78667J108 2,122,156 1,708,926 413.55 88,239 643.50 0.1051
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM 78667J108 413,230 336,537 438.81 11,868 114.38 0.0185
2020-02-14 2019-12-31 13F SAGE THERAPEUTICS COM 78667J108 76,693 -26,950 -26.00 5,536 -61.93 0.0063
2019-11-14 2019-09-30 13F SAGE THERAPEUTICS COM 78667J108 103,643 103,643 35.14 14,540 162.64 0.0179
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM 78667J108 0 -1,546 -100.00 0 -100.00
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM 78667J108 1,546 -97,363 -98.44 218 -98.59 0.0003
2018-08-14 2018-06-30 13F SAGE THERAPEUTICS COM 78667J108 98,909 92,366 1,411.68 15,482 1,368.88 0.0202
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM 78667J108 6,543 -31,500 -82.80 1,054 -83.18 0.0014
2018-02-14 2017-12-31 13F SAGE THERAPEUTICS COM 78667J108 38,043 38,043 481.43 6,266 494.50 0.0086
2017-11-14 2017-09-30 13F SAGE THERAPEUTICS COM 78667J108 0 -64,597 -100.00 0 -100.00
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM 78667J108 64,597 32,882 103.68 5,145 128.26 0.0085
2017-05-15 2017-03-31 13F SAGE THERAPEUTICS COM 78667J108 31,715 -4,285 -11.90 2,254 22.63 0.0040
2017-02-14 2016-12-31 13F SAGE THERAPEUTICS COM 78667J108 36,000 25,975 259.10 1,838 297.84 0.0031
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM 78667J108 10,025 -6,953 -40.95 462 -9.77 0.0008
2016-08-15 2016-06-30 13F SAGE THERAPEUTICS COM 78667J108 16,978 16,978 69.36 512 10.82 0.0009
2016-05-16 2016-03-31 13F SAGE THERAPEUTICS COM 78667J108 0 -5,878 -100.00 0 -100.00
2016-02-16 2015-12-31 13F SAGE THERAPEUTICS COM 78667J108 5,878 5,878 0.00 343 0.0005
2015-11-16 2015-09-30 13F SAGE THERAPEUTICS COM 78667J108 0 0 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM Call 10,000 568 n/a n/a n/a
2020-11-16 2020-09-30 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F SAGE THERAPEUTICS COM Call 25,000 1,040 n/a n/a n/a
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SAGE THERAPEUTICS COM Call 70,300 0.00 5,075 -48.54 n/a n/a n/a
2019-11-14 2019-09-30 13F SAGE THERAPEUTICS COM Call 70,300 0.00 9,862 -23.38 n/a n/a n/a
2019-08-14 2019-06-30 13F SAGE THERAPEUTICS COM Call 70,300 0.00 12,871 15.11 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Call 70,300 -29.91 11,181 16.37 n/a n/a n/a
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM Call 100,300 5.25 9,608 -28.62 n/a n/a n/a
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM Call 95,300 0.00 13,461 -9.76 n/a n/a n/a
2018-08-14 2018-06-30 13F SAGE THERAPEUTICS COM Call 95,300 111.78 14,917 105.81 n/a n/a n/a
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM Call 45,000 50.00 7,248 46.69 n/a n/a n/a
2018-02-14 2017-12-31 13F SAGE THERAPEUTICS COM Call 30,000 0.00 4,941 164.37 n/a n/a n/a
2017-11-14 2017-09-30 13F SAGE THERAPEUTICS COM Call 30,000 200.00 1,869 134.80 n/a n/a n/a
2017-08-14 2017-06-30 13F SAGE THERAPEUTICS COM Call 10,000 796 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-14 2024-12-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F SAGE THERAPEUTICS COM Put 41,100 -10.85 297 -40.80 n/a n/a n/a
2024-08-14 2024-06-30 13F SAGE THERAPEUTICS COM Put 46,100 501 n/a n/a n/a
2023-05-15 2023-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F SAGE THERAPEUTICS COM Put 20,000 0.00 763 -2.68 n/a n/a n/a
2022-11-14 2022-09-30 13F SAGE THERAPEUTICS COM Put 20,000 0.00 783 21.21 n/a n/a n/a
2022-08-15 2022-06-30 13F SAGE THERAPEUTICS COM Put 20,000 0.00 646 -2.42 n/a n/a n/a
2022-05-16 2022-03-31 13F SAGE THERAPEUTICS COM Put 20,000 662 n/a n/a n/a
2021-11-15 2021-09-30 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F SAGE THERAPEUTICS COM Put 75,000 4,261 n/a n/a n/a
2020-11-16 2020-09-30 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F SAGE THERAPEUTICS COM Put 30,000 1,247 n/a n/a n/a
2020-05-15 2020-03-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F SAGE THERAPEUTICS COM Put 32,000 0.00 2,310 -48.54 n/a n/a n/a
2019-11-14 2019-09-30 13F SAGE THERAPEUTICS COM Put 32,000 0.00 4,489 -23.38 n/a n/a n/a
2019-08-14 2019-06-30 13F SAGE THERAPEUTICS COM Put 32,000 0.00 5,859 15.11 n/a n/a n/a
2019-05-15 2019-03-31 13F SAGE THERAPEUTICS COM Put 32,000 -13.51 5,090 43.62 n/a n/a n/a
2019-02-14 2018-12-31 13F SAGE THERAPEUTICS COM Put 37,000 80.49 3,544 22.38 n/a n/a n/a
2018-11-14 2018-09-30 13F SAGE THERAPEUTICS COM Put 20,500 32.26 2,896 19.37 n/a n/a n/a
2018-08-14 2018-06-30 13F SAGE THERAPEUTICS COM Put 15,500 3.33 2,426 0.41 n/a n/a n/a
2018-05-15 2018-03-31 13F SAGE THERAPEUTICS COM Put 15,000 -3.23 2,416 -0.41 n/a n/a n/a
2017-02-14 2016-12-31 13F SAGE THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F SAGE THERAPEUTICS COM Put 20,000 921 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.